Best Practice & Research Clinical Haematology
Volume 22, Issue 4 , Pages 489-494, December 2009

Mechanisms of mutations in myeloproliferative neoplasms

  • Ross L. Levine, MD (Assistant Member)

      Affiliations

    • Corresponding Author InformationTel.: +1 646 888 2767; Fax: +1 646 422 0856.

Human Oncology and Pathogenesis Program and Leukemia Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, Box 20, New York, NY 10065, USA

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1521-6926(09)00060-7

doi:10.1016/j.beha.2009.08.006

Best Practice & Research Clinical Haematology
Volume 22, Issue 4 , Pages 489-494, December 2009

Article Tools

* Image Usage & Resolution